SE9700642D0 - Medel och sätt för förebyggande och behandling av det metabola syndromet - Google Patents

Medel och sätt för förebyggande och behandling av det metabola syndromet

Info

Publication number
SE9700642D0
SE9700642D0 SE9700642A SE9700642A SE9700642D0 SE 9700642 D0 SE9700642 D0 SE 9700642D0 SE 9700642 A SE9700642 A SE 9700642A SE 9700642 A SE9700642 A SE 9700642A SE 9700642 D0 SE9700642 D0 SE 9700642D0
Authority
SE
Sweden
Prior art keywords
ways
treating
preventing
metabolic syndrome
syndrome
Prior art date
Application number
SE9700642A
Other languages
English (en)
Inventor
Per Maarin
Original Assignee
Kronvall Stefan Med Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kronvall Stefan Med Ab filed Critical Kronvall Stefan Med Ab
Priority to SE9700642A priority Critical patent/SE9700642D0/sv
Publication of SE9700642D0 publication Critical patent/SE9700642D0/sv
Priority to JP53641898A priority patent/JP2001513082A/ja
Priority to RU99120189/14A priority patent/RU2198679C2/ru
Priority to CNB988027828A priority patent/CN1178696C/zh
Priority to KR1019997007690A priority patent/KR20000075626A/ko
Priority to NZ337123A priority patent/NZ337123A/en
Priority to AU63023/98A priority patent/AU743277B2/en
Priority to EP98907037A priority patent/EP1030682A1/en
Priority to CA002282467A priority patent/CA2282467A1/en
Priority to PCT/GB1998/000574 priority patent/WO1998036770A1/en
Priority to NO994053A priority patent/NO994053L/no
Priority to US09/379,832 priority patent/US6274582B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
SE9700642A 1997-02-24 1997-02-24 Medel och sätt för förebyggande och behandling av det metabola syndromet SE9700642D0 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE9700642A SE9700642D0 (sv) 1997-02-24 1997-02-24 Medel och sätt för förebyggande och behandling av det metabola syndromet
PCT/GB1998/000574 WO1998036770A1 (en) 1997-02-24 1998-02-24 Preparations for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor
KR1019997007690A KR20000075626A (ko) 1997-02-24 1998-02-24 코르티솔 합성 저해제와 함께 인간 성장 호르몬을 함유한 대사이상증의 치료를 위한 제제
RU99120189/14A RU2198679C2 (ru) 1997-02-24 1998-02-24 Препараты для лечения метаболического синдрома, содержащие гормон роста человека в комбинации с ингибитором синтеза кортизола
CNB988027828A CN1178696C (zh) 1997-02-24 1998-02-24 含人体生长激素和皮质甾醇合成抑制剂的用于治疗代谢综合症的制剂
JP53641898A JP2001513082A (ja) 1997-02-24 1998-02-24 ヒト成長ホルモンとコルチゾール合成阻害剤とを組み合わせて含む代謝症候群の処置用製剤
NZ337123A NZ337123A (en) 1997-02-24 1998-02-24 Method, use and kit for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor
AU63023/98A AU743277B2 (en) 1997-02-24 1998-02-24 Preparations for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor
EP98907037A EP1030682A1 (en) 1997-02-24 1998-02-24 Preparations for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor
CA002282467A CA2282467A1 (en) 1997-02-24 1998-02-24 Preparations for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor
NO994053A NO994053L (no) 1997-02-24 1999-08-23 Preparater for behandlingen av metabolsk syndrom inneholdende humant veksthormon i kombinasjon med en kortisolsyntese-inhibitor
US09/379,832 US6274582B1 (en) 1997-02-24 1999-08-24 Preparation for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700642A SE9700642D0 (sv) 1997-02-24 1997-02-24 Medel och sätt för förebyggande och behandling av det metabola syndromet

Publications (1)

Publication Number Publication Date
SE9700642D0 true SE9700642D0 (sv) 1997-02-24

Family

ID=20405901

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9700642A SE9700642D0 (sv) 1997-02-24 1997-02-24 Medel och sätt för förebyggande och behandling av det metabola syndromet

Country Status (12)

Country Link
US (1) US6274582B1 (sv)
EP (1) EP1030682A1 (sv)
JP (1) JP2001513082A (sv)
KR (1) KR20000075626A (sv)
CN (1) CN1178696C (sv)
AU (1) AU743277B2 (sv)
CA (1) CA2282467A1 (sv)
NO (1) NO994053L (sv)
NZ (1) NZ337123A (sv)
RU (1) RU2198679C2 (sv)
SE (1) SE9700642D0 (sv)
WO (1) WO1998036770A1 (sv)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642236B1 (en) * 1998-12-14 2003-11-04 Cortendo Ab Methods for prophylactic treatment of cardiovascular disease with inhibitor of cortisol synthesis
NZ514290A (en) * 1999-04-01 2003-08-29 Akzo Nobel Nv Formulation comprising testosterone undecanoate and castor oil
US6428809B1 (en) 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
AU2004200545B2 (en) * 1999-08-18 2007-05-17 Microdose Therapeutx, Inc. Metering and packaging of controlled release medication
GB0001449D0 (en) * 2000-01-21 2000-03-08 Cortendo Ab Compositions
SE0001899D0 (sv) 2000-05-22 2000-05-22 Pharmacia & Upjohn Ab New compounds
RS44304A (en) 2001-11-22 2007-06-04 Biovitrum Ab., Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
US6967194B1 (en) * 2002-09-18 2005-11-22 Susan Matsuo Bio-identical hormones and method of use
IL152574A (en) * 2002-10-31 2009-09-22 Transpharma Medical Ltd A system for passing through the skin of dry items or dried medicines
US7662404B2 (en) * 2002-10-31 2010-02-16 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides
US7383084B2 (en) * 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
US8133505B2 (en) * 2002-10-31 2012-03-13 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
JO2505B1 (en) * 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
US20050031718A1 (en) * 2003-04-10 2005-02-10 Pharmanex, Llc Sea Buckthorn compositions and associated methods
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
DE102004034640A1 (de) 2004-07-16 2006-02-16 Institut für Molekular- und Systemmedizin Verfahren zur systemischen Biokorrektur eines Organismus
ES2377526T3 (es) * 2005-01-10 2012-03-28 Cortendo Ab (Publ) 2S,4R ketoconazol para el tratamiento de la diabetes, el síndrome metabólico y otras afecciones
KR100705981B1 (ko) * 2005-10-12 2007-04-10 주식회사 리제론 인간 성장호르몬을 포함하는 탈모방지 또는 발모촉진용조성물
ZA200902127B (en) 2006-10-02 2010-07-28 Cortendo Invest Ab Ketoconazole enantiomer in humans
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
GB2477256B (en) 2008-11-07 2013-12-25 Univ Sheffield Determination of predisposition towards subclinical Cushing's syndrome or incidentaloma
TWI589313B (zh) 2010-01-05 2017-07-01 麥可朵斯斯若波特公司 醫藥遞送封裝及吸入器
EP2524039B1 (en) * 2010-01-11 2017-11-29 CuRNA, Inc. Treatment of sex hormone binding globulin (shbg) related diseases by inhibition of natural antisense transcript to shbg
JP6618488B2 (ja) 2014-06-17 2019-12-11 メルク・シャープ・エンド・ドーム・ベー・フェー テストステロンウンデカノエートの安定な製剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3825469B2 (ja) * 1994-08-09 2006-09-27 メタボリツク シンドローム イー イエテボルグ アクチエボラグ Ｉｉ型糖尿病治療薬剤としてのケトコナゾール、および、その関連物質の使用法

Also Published As

Publication number Publication date
JP2001513082A (ja) 2001-08-28
NO994053D0 (no) 1999-08-23
US6274582B1 (en) 2001-08-14
NZ337123A (en) 2005-05-27
KR20000075626A (ko) 2000-12-26
RU2198679C2 (ru) 2003-02-20
AU6302398A (en) 1998-09-09
CA2282467A1 (en) 1998-08-27
CN1178696C (zh) 2004-12-08
WO1998036770A1 (en) 1998-08-27
NO994053L (no) 1999-09-24
AU743277B2 (en) 2002-01-24
CN1248170A (zh) 2000-03-22
EP1030682A1 (en) 2000-08-30

Similar Documents

Publication Publication Date Title
SE9700642D0 (sv) Medel och sätt för förebyggande och behandling av det metabola syndromet
SE0202857D0 (sv) Method and compositions for preventing hormone induced adverse effects
NO931766L (no) Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin
NO20010844L (no) Regulering av substrataktivitet
DK0977562T3 (da) Fremgangsmåder og sammensætninger til indgivelse af taxaner
TR199901669T2 (xx) Erkeklerdeki ereksiyon probleminin tedavisi i�in gerekli dozaj �ekilleri ve metod.
PT804252E (pt) Agentes queladores metalicos que contem monoaminas diamidas e tiois
DE69710065D1 (de) Androsten-derivate
DE69933049D1 (de) Pharmazeutische zusammensetzung und verwendung von rnsaid zur behandlung der entzündung
DE69725860D1 (de) PLAN ZUR VERABREICHUNG VON H+, K+-ATPase INHIBITOREN
HUP9901360A2 (hu) Cimicifuga racemosa-ból származó extraktum alkalmazása
AU2284001A (en) Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
SE9603725D0 (sv) New teatment
MX9806082A (es) Preparacion farmaceutica combinada de analogos de lhrh y antiestrogenos para el tratamiento de trastornos ginecologicos.
NO962450L (no) Forblanding for å fremme vekst hos fisk, samt anvendelse av blandingen
NO955084D0 (no) Estrensteroider som nevrokjemiske initiatorer for forandring i menneskets hypotalamiske funksjon og beslektede farmasöytiske blandinger og metoder
HUP0101005A2 (hu) Szteroid aromatáz gátlót tartalmazó gyógyszer emlőrák megelőzésére és/vagy kezelésére
SE0200256D0 (sv) New composition, methods and use
HK1006542A1 (en) Synergistic compositions
KR100348888B1 (en) Method for relieving violence and spare diet of estrous deer and method for promoting growth of antlers thereof
ATE329613T1 (de) Wachstumhormone inhibitoren enthaltende pharmazeutische zubereitungen oder ihre biologisch aktive fragmente zur behandlung von uterinen myomas
UA37528A (uk) Спосіб профілактики післяопераційних ускладнень у дітей після тонзилектомії
ES2162545A1 (es) Productos naturales triciclicos como inhibidores de la proteina quimioatrayente de monocitos 1.
UA27023C2 (uk) Спосіб профілактики та лікуваhhя серцево-судиhhих захворюваhь